KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Revenue (2016 - 2025)

Historic Revenue for TherapeuticsMD (TXMD) over the last 16 years, with Q3 2025 value amounting to $784000.0.

  • TherapeuticsMD's Revenue rose 4332.72% to $784000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 7518.8%. This contributed to the annual value of $1.8 million for FY2024, which is 3525.35% up from last year.
  • Per TherapeuticsMD's latest filing, its Revenue stood at $784000.0 for Q3 2025, which was up 4332.72% from $952000.0 recorded in Q2 2025.
  • TherapeuticsMD's Revenue's 5-year high stood at $68.6 million during Q4 2022, with a 5-year trough of $53000.0 in Q3 2023.
  • Over the past 5 years, TherapeuticsMD's median Revenue value was $547000.0 (recorded in 2024), while the average stood at $8.5 million.
  • In the last 5 years, TherapeuticsMD's Revenue tumbled by 9926.79% in 2023 and then skyrocketed by 93207.55% in 2024.
  • TherapeuticsMD's Revenue (Quarter) stood at $18.7 million in 2021, then skyrocketed by 267.09% to $68.6 million in 2022, then tumbled by 99.27% to $502000.0 in 2023, then soared by 32.87% to $667000.0 in 2024, then increased by 17.54% to $784000.0 in 2025.
  • Its Revenue was $784000.0 in Q3 2025, compared to $952000.0 in Q2 2025 and $393000.0 in Q1 2025.